Close
Smartlab Europe
Achema middle east

Innovacyn introduces eye, ear formulations

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

UK Clinical Trial Regulatory Reforms Aim to Boost Research

A number of regulatory changes have been released by...

Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug

Teva Pharmaceutical Industries and Royalty Pharma have signed a...

Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery

An integrated partnership has been formed between Pierre Fabre...
- Advertisement -

Innovacyn, a provider of human and animal healthcare products, has added Vetericyn VF Ophthalmic Wash and Vetericyn VF Otic Rinse to its professional-strength animal healthcare line.

The antimicrobial solution found in the Ophthalmic Wash and Otic Rinse inhibits antibiotic-resistant strains of bacteria (including staph and MRSA) as well as fungi, viruses and spores.

Innovacyn claims Ophthalmic Wash and Otic Rinse are steroid-free, antibiotic-free and contain no alcohol or iodine and consists of oxychlorine compounds similar to those produced by the animal’s own immune system.

The Vetericyn VF Ophthalmic Wash is a twist-top that cleans wounds, eliminates the eye infections caused by viruses or fungi, and inhibits bacteria.

It also works as a no-rinse flush to relieve irritated eyes, or debride eye abrasions and wounds in the surrounding area of the eye.

The Vetericyn VF Otic Rinse inhibits infections, cleans wounds, and speeds the healing process in the outer ear and ear canal and also eliminates skin irritation.

 

Latest stories

Related stories

UK Clinical Trial Regulatory Reforms Aim to Boost Research

A number of regulatory changes have been released by...

Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug

Teva Pharmaceutical Industries and Royalty Pharma have signed a...

Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery

An integrated partnership has been formed between Pierre Fabre...

Revvity and Lilly Expand Lilly TuneLab Access via Signals

Revvity, Inc. announced a collaboration with Eli Lilly and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »